Cancer Research Nottingham
  • Print
   
   

Recent Funding Awards

Dr Nigel Mongan & Prof David Heery
Prostate Cancer UK (£183,000)
Novel therapeutic targets for the prevention and treatment of hormonerefractory prostate cancer.
 
Dr Abdolrahman Shams-Nateri
Cancer Research UK (£297,000)
Nuclear Isoform of the Fbw7 (hCDC4) Tumour suppressor gene expression: cell fate control and signal integration in small intestine and colon.
 
Dr Abdolrahman Shams-Nateri
Cancer Research UK (£160,000)
Transcriptional activators under control of the Fbxw7 (Fbw7, hCDC4) E3-Ubiquitin ligase receptor: lineage potential and its commitment to cancer.
 
Dr Marius Georgiou
Cancer Research UK (£383,540)
A genetic dissection of tumour progression and invasion in the context of a living epithelium.
 
Prof Lindy Durrant, Dr Ian Spendlove
Cancer Research UK (£225,000)
Platform technology for producing anti-glycolipid monoclonal antibodies: lead optimisation of anti-Lewis g monoclonal antibodies to fucosyl-GM1 and Gb3. 
 
Prof John Atherton, Dr Karen Robinson, Prof Sue Watson, Dr Raheela Khan
Cancer Research UK (£215,834)
The role of H. pylori vacuolating cytotoxin, VacA, in gastric carcinogenesis. 
 
Dr Stewart Martin
Breast Cancer Campaign (£185,670)
Calpain and calspstatin in breast cancer. 
 
Prof Richard Grundy
Joseph Foote Foundation
The role of histone deacetylase inhibition in malignant childhood ependymoma.
 
Prof David Walker
Trent Local Children's Research Network (£95,886)
Children's cancer and leukaemia support.
 
Dr Kathryn Almack
Cancer Research UK (£78,710)
End of life care: the experiences and needs of lesbian, gay, bisexual and trans (LGBT) elders.
 
Dr Jayne Brown
Cancer Research UK (£67,589)
Understanding the role of nurses in decisions to uce anticipatory prescriptions to manage symptoms and distress in the last days of life: a prospective community based case study using mixed methods.
 
Dr Matthew Grainge, Dr Joe West, Dr Tim Card
Cancer Research UK (£50,245)
What are the opportunities for preventing deaths due to venous thromboembolism in people with cancer?
 
Prof Nigel Russell, Dr Claire Seedhouse
Nottinghamshire Leukaemia Appeal (£43,460)
Targeting leukaemia stem and progenitor cells.
 
Dr Stewart Martin, Prof Ian Ellis, Dr Sarah Storr
Breast Cancer Research Trust (£39,000)
HER2 signalling and Calpain in breast cancer.
 
Prof John Britton, Dr Jo Leonardi-Bee, Dr Yue Huang, Ms Elena Ratschen, Prof AD McNeill
Cancer Research UK (£35,200)
Health impacts of smoking in mental health populations.
 
Prof John Britton, Prof AD McNeill
Cancer Research UK (£34,997)
A study of the effect of point-if-sale display legislation and packaging on smoking behaviours and brand awareness among young people in England.
 
Prof Uwe Vinkemeier, Prof Ian Ellis
Breast Cancer Campaign (£19,810)
STAT protein paracrystals: novel targets for breast cancer diagnosis and therapy?
 
Dr Nicole Clarke
Breast Cancer Campaign (£19,103)
IRF1 as a new metastasis suppressor gene in breast cancer.
 
Dr Stewart Martin
Breast Cancer Campaign (£18,000)
Role of macrophage and their associated factors in lymphovascular invasion in breast cancer.
 
Dr Srinivasan Madhusudan
Breast Cancer Campaign (£15,000)
Evaluation of SMUG1 in breast cancer.